Opinion: Companies should anticipate greater pressure to reassess the costs and benefits of filing patent validity challenges ...
Danish pharma giant says in process of challenging earlier verdict, where court allowed Dr Reddy’s to make and export ...
A fledgling social media platform has asked the U.S. Patent and Trademark Office to cancel trademarks for Twitter so it can ...
What's really holding America back in the biopharma race against China isn't just Beijing's subsidies or cheaper labor. It's ...
Patent disputes in the United States often unfold on two parallel tracks: the federal district courts and the Patent Trial and Appeal Board (PTAB). While these forums serve different purposes, they ...
PRINCETON, N.J. —The U.S. Patent and Trademark Office has issued a new patent (patent number US 12,464,196 B2) to Triveni ...
The UPC has granted a preliminary injunction effective for Germany, France, Italy, the Netherlands and Ireland against a Chinese medical ...
Generic drugmakers face U.S. pricing pressure, but TEVA, SDZNY and RDY gain momentum through complex generics and biosimilars.
BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / In recent years, LIXTE (NASDAQ:LIXT) has been defined by LB-100, its first-in-class PP2A inhibitor with a mechanism that unlocks new therapeutic ...
Windows Latest found a new patent titled "IN_EAR AUTHENTICATION" that imagines buds with a new built-in authentication..
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback